2023 SPEAKERS
Robert Avery, MD
California Retina Consultants
Caroline Baumal, MD
Apellis / New England Eye Center, Tufts Medical Center
Maria Berrocal, MD
Berrocal & Associates
Paul Bresge
Ray Therapeutics
Cariad Chester
TCG Crossover
Lori-Ann Christie, PhD
Visionary Venture Fund
Daniel Chung, DO
SparingVision
Thomas Ciulla, MD, MBA
Indiana University School of Medicine / Midwest Eye Institute
Anupam Dalal, MD
Acuta Capital Partners
Justis Ehlers, MD
Cole Eye Institute at Cleveland Clinic
David Esposito
ONL Therapeutics
Daniela Ferrara, MD, MSc, PhD
Genentech/Roche
Peter Francis, MD, PhD
Ray Therapeutics
Cedric Francois, MD, PhD
Apellis
Paul Hallen
Alcon
Mark Humayun, MD, PhD
University of Southern California Roski Eye Institute
Jason Jun
Citi
Peter Kaiser, MD
Cole Eye Institute
Baruch Kuppermann, MD, PhD
University of California
George Lasezkay, PharmD
Clearside Biomedical
Sun Young Lee, MD, PhD
USC Roski Eye Institute
Jennifer I. Lim, MD, FARVO
University of Illinois Chicago
Anat Loewenstein, MD
Tel Aviv Medical Center / Medical School, Tel Aviv University
Adrian Morris
Jcyte
Andrew Moshfeghi, MD, MBA
University of Southern California
James C. Murray
ExSight Ventures
Michael O’Rourke
Revana Therapeutics
Céline Olmiere, PhD
Théa Open Innovation
Ram Palanki, PharmD
REGENXBIO
John S. Pollack, MD
Illinois Retina Associates / jCyte
Carlos Quezada Ruiz, MD
Genentech
Firas Rahhal, MD
ExSight Ventures & Retina Vitreous Associates Medical Group
SriniVas R. Sadda, MD
Doheny Eye Institute/UCLA - David Geffen School of Medicine
David Sarraf, MD
Stein Eye Institute at UCLA
Ursula Schmidt-Erfurth, MD
The University Eye Hospital, Vienna, Austria
Cameron Taylor
BofA Securities | Life Sciences
Omer Trivizki, MD, MBA
Tel-Aviv Medical Center / Tel Aviv Medical Center
Lejla Vajzovic, MD
Duke University School of Medicine
Nadia Waheed, MD
Tufts University School of Medicine
Anthony Wallace
Bausch + Lomb